25 March 2021
IXICO plc
("IXICO" or the "Company")
Director/PDMR Dealing
IXICO plc (AIM: IXI), the data analytics company delivering insights in neuroscience, announces that Mark Warne, Non-Executive Director, today purchased 14,250 ordinary shares in the Company at an average price of 63 pence.
For further information please contact:
IXICO plc +44 20 3763 7499
Giulio Cerroni, Chief Executive Officer
Grant Nash, Chief Financial Officer
Cenkos Securities plc (Nominated adviser and sole broker) +44 20 7397 8900
Giles Balleny / Max Gould (Corporate Finance)
Michael F Johnson / Russell Kerr (Sales)
| Walbrook PR Ltd | +44 (0)20 7933 8780
| |
| Paul McManus / Lianne Cawthorne / | IXICO@walbrookpr.com | |
| Alice Woodings
| | |
The below makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:
| Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014 | |||||||
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||||
| a. | Name | Mark Warne | |||||
| 2 | Reason for notification | On market purchase | |||||
| a. | Position/Status | Non-Executive Director | |||||
| b. | Initial notification/ Amendment | Initial notification | |||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||||
| a. | Name | IXICO plc | |||||
| b. | LEI | 2138005M1F59O6HWSA97 | |||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
| a. | Description of the financial instrument, type of instrument | Ordinary shares of 1p each ISIN: GB00BCLY7L40
| |||||
| b. | Nature of the transaction | Purchase of ordinary shares | |||||
| c. | Price(s) and volume(s) | | | | | | |
| | Price(s) per share | Volume(s) | | ||||
| £0.66 | 250 shares | | |||||
| | £0.64 | 1500 shares | | ||||
| | £0.65 | 1500 shares | | ||||
| | £0.63 | 1500 shares | | ||||
| | £0.61 | 1500 shares | | ||||
| | £0.61 | 1500 shares | | ||||
| | £0.63 | 1500 shares | | ||||
| | £0.62 | 5000 shares | | ||||
|
| |||||||
| d. | Aggregated information - Aggregated Volume - Price |
14,250 shares £0.63 | |||||
| e. | Date of the transaction | 24 March 2021 | |||||
| f. | Place of the transaction | London Stock Exchange, AIM Market | |||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
